309 related articles for article (PubMed ID: 25576832)
1. Mechanistic insights into the inhibitory effects of palmitoylation on cytosolic thioredoxin reductase and thioredoxin.
Qin H; Liang W; Xu Z; Ye F; Li X; Zhong L
Biochimie; 2015 Mar; 110():25-35. PubMed ID: 25576832
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin and thioredoxin reductase control tissue factor activity by thiol redox-dependent mechanism.
Wang P; Wu Y; Li X; Ma X; Zhong L
J Biol Chem; 2013 Feb; 288(5):3346-58. PubMed ID: 23223577
[TBL] [Abstract][Full Text] [Related]
3. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
Huang J; Xu J; Tian L; Zhong L
Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
[TBL] [Abstract][Full Text] [Related]
4. New insights into the posttranslational regulation of human cytosolic thioredoxin by S-palmitoylation.
Xu Z; Zhong L
Biochem Biophys Res Commun; 2015 May; 460(4):949-56. PubMed ID: 25839660
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1.
Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A
Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724
[TBL] [Abstract][Full Text] [Related]
6. Acetaminophen reactive intermediates target hepatic thioredoxin reductase.
Jan YH; Heck DE; Dragomir AC; Gardner CR; Laskin DL; Laskin JD
Chem Res Toxicol; 2014 May; 27(5):882-94. PubMed ID: 24661219
[TBL] [Abstract][Full Text] [Related]
7. The C-terminal selenenylsulfide of extracellular/non-reduced thioredoxin reductase endows this protein with selectivity to small-molecule electrophilic reagents under oxidative conditions.
Qin H; Guo C; Chen B; Huang H; Tian Y; Zhong L
Front Mol Biosci; 2024; 11():1274850. PubMed ID: 38523661
[TBL] [Abstract][Full Text] [Related]
8. Thioredoxin reductase 1 and NADPH directly protect protein tyrosine phosphatase 1B from inactivation during H
Dagnell M; Pace PE; Cheng Q; Frijhoff J; Östman A; Arnér ESJ; Hampton MB; Winterbourn CC
J Biol Chem; 2017 Sep; 292(35):14371-14380. PubMed ID: 28684416
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions.
Du Y; Wu Y; Cao X; Cui W; Zhang H; Tian W; Ji M; Holmgren A; Zhong L
Biochimie; 2009 Mar; 91(3):434-44. PubMed ID: 19059456
[TBL] [Abstract][Full Text] [Related]
10. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidation.
Watson WH; Heilman JM; Hughes LL; Spielberger JC
Biochem Biophys Res Commun; 2008 Apr; 368(3):832-6. PubMed ID: 18267104
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability.
Wang Y; Zhang H; Holmgren A; Tian W; Zhong L
Oncol Rep; 2008 Dec; 20(6):1479-87. PubMed ID: 19020731
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory nitrosylation of mammalian thioredoxin reductase 1: Molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance.
Engelman R; Ziv T; Arnér ESJ; Benhar M
Free Radic Biol Med; 2016 Aug; 97():375-385. PubMed ID: 27377780
[TBL] [Abstract][Full Text] [Related]
14. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
[TBL] [Abstract][Full Text] [Related]
15. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.
Du Y; Zhang H; Lu J; Holmgren A
J Biol Chem; 2012 Nov; 287(45):38210-9. PubMed ID: 22977247
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity.
Fang J; Lu J; Holmgren A
J Biol Chem; 2005 Jul; 280(26):25284-90. PubMed ID: 15879598
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo.
Fang J; Holmgren A
J Am Chem Soc; 2006 Feb; 128(6):1879-85. PubMed ID: 16464088
[TBL] [Abstract][Full Text] [Related]
18. Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities.
Gorlatov SN; Stadtman TC
Arch Biochem Biophys; 1999 Sep; 369(1):133-42. PubMed ID: 10462449
[TBL] [Abstract][Full Text] [Related]
19. A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis.
Liu J; Mu C; Yue W; Li J; Ma B; Zhao L; Liu L; Chen Q; Yan C; Liu H; Hao X; Zhu Y
Free Radic Biol Med; 2013 Oct; 63():485-94. PubMed ID: 23732520
[TBL] [Abstract][Full Text] [Related]
20. Activity assays of mammalian thioredoxin and thioredoxin reductase: fluorescent disulfide substrates, mechanisms, and use with tissue samples.
Montano SJ; Lu J; Gustafsson TN; Holmgren A
Anal Biochem; 2014 Mar; 449():139-46. PubMed ID: 24374250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]